HomeSSKN • NASDAQ
STRATA Skin Sciences Inc
$2.95
Jan 13, 2:37:03 PM GMT-5 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$2.95
Day range
$2.94 - $3.04
Year range
$2.54 - $6.00
Market cap
12.30M USD
Avg Volume
8.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
8.80M-0.62%
Operating expense
6.96M24.98%
Net income
-2.12M-101.52%
Net profit margin
-24.12-102.69%
Earnings per share
-0.52-77.90%
EBITDA
-414.00K-149.64%
Effective tax rate
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
7.06M-0.97%
Total assets
40.20M-14.81%
Total liabilities
30.86M-0.45%
Total equity
9.34M
Shares outstanding
4.17M
Price to book
1.32
Return on assets
-10.36%
Return on capital
-15.95%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
-2.12M-101.52%
Cash from operations
-302.00K85.05%
Cash from investing
-62.00K-131.96%
Cash from financing
1.94M1,968.27%
Net change in cash
1.58M181.81%
Free cash flow
1.38M225.27%
About
Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations. The company's flagship product, XTRAC, is a medical device that allows for a trained dermatologist to treat skin conditions like Vitiligo and Psoriasis with monochromatic UV Light. Following completion of a successful conformity assessment procedure, Strata Skin Sciences has also been granted CE Mark approval for sale of MelaFind in the European Union. In July 2015, the company acquired PhotoMedex Inc. and is planning to relocate its headquarters from Irvington, New York to Horsham, Pennsylvania in Montgomery County. Wikipedia
Founded
Jan 1, 1989
Employees
99
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu